Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abaxis Inc (NASDAQ:ABAX)

During the Trading Day
53.09 +0.03 / +0.06%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
53.08 -0.0106 / -0.02%
Volume: 739.00
Health Technology
Medical Specialties

Company Description

ABAXIS, Inc. develops, manufactures and markets portable blood analysis systems. It operates through two segments: Medical Market and Veterinary Market. The Medical Market segment serves a worldwide customer group consisting of military installations, physicians' office practices across all specialties, urgent care, outpatient and walk-in clinics health screening operations, home care providers, nursing homes, ambulance companies, oncology treatment clinics, dialysis centers, pharmacies and hospital labs. The Veterinary Market segment serves a customer group consisting of companion animal hospitals, animal clinics with mixed practices of small animals, birds and reptiles, equine and bovine practitioners, veterinary emergency clinics, veterinary referral hospitals, universities, government, pharmaceutical companies, biotechnology companies and private research laboratories. ABAXIS was founded by Vladimir E. Ostoich in April 1989 and is headquartered in Union City, CA.

Contact Information

3240 Whipple Road
Union City California 94587
P:(510) 675-6500
Investor Relations:



Mutual fund holders61.72%
Individual stakeholders6.28%
Other institutional43.87%

Top Executives

Clinton H. SeversonChairman & Chief Executive Officer
Donald Peter WoodPresident & Chief Operating Officer
Ross TaylorCFO, VP-Investor Relations & Finance
Kenneth P. AronChief Technology Officer
Gregory BennettVice President-Engineering